Nucala 100 mg/mL, Injektionslösung im Fertigpen

7680673500026 CH-67350 Injektionslösung im Fertigpen

Associated product:

NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
Nucala 100 mg/mL, Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
1 / 3
google

Article details

Package size
3 x 1
Selling units
3
Measure
Stück
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/07/2025
Patient information leaflet
Français
26/07/2025
Patient information leaflet
Italien
26/07/2025
Summary of Product Characteristics
Allemand
26/07/2025
Summary of Product Characteristics
Français
26/07/2025
Summary of Product Characteristics
Italien
26/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
67350
Drug name
Nucala, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
R03DX09
Authorization status
Z
Dispensing category
B
First authorization
13/02/2020
Authorization expiration date
31/12/9999
IT Number
03.04.5.
Domain
Human medicine
Field of application
Eosinophiles Asthma, EGPA, CRSwNP, HES

Package details

Description (FR)
NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
Description (DE)
NUCALA Inj Lös 100 mg/ml Fertigpen 3 Stk
Market launch
13/02/2020
Narcotic (BTM)
No

Other package sizes (1)

NUCALA sol inj 100 mg/ml stylo prérempli
1 STU
GTIN: 7680673500019
View